Prominent investor Andrew Kang is highlighting a potential long-term investment theme in biotechnology and pharmaceuticals. He is seeking companies working on breakthroughs in neuroplasticity and cognitive enhancement. This suggests a growing interest in a sector that could represent a significant future market.